Hot Features
Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
XIANYANG, China, Aug. 23, 2018 (GLOBE NEWSWIRE) -- Biostar Pharmaceuticals, Inc. (NASDAQ: BSPM) (the “Company”), a PRC-based manufacturer and marketer of pharmaceutical and health supplement...
Biostar Announces Receipt of Nasdaq Continued Listing Deficiency Notice PR Newswire XIANYANG, China, April 23, 2018 XIANYANG, China, April 23, 2018 /PRNewswire/ -- Biostar Pharmaceuticals, Inc...
Biostar Pharmaceuticals, Inc. Announces Plans to Launch a New eCommerce Sales Platform PR Newswire XIANYANG, China, Feb. 21, 2018 XIANYANG, China, Feb. 21, 2018 /PRNewswire/ -- Biostar...
Shaanxi Aoxing Pharmaceutical Co., Ltd. Renewed its GMP Certification PR Newswire XIANYANG, China, Feb. 7, 2018 XIANYANG, China, Feb. 7, 2018 /PRNewswire/ -- Biostar Pharmaceuticals, Inc...
Biostar Regains Compliance with NASDAQ Continued Listing Requirement PR Newswire XIANYANG, China, Dec. 4, 2017 XIANYANG, China, Dec. 4, 2017 /PRNewswire/ -- Biostar Pharmaceuticals, Inc...
Biostar Pharmaceuticals, Inc. Announces Its Quarterly Results for Nine Months Ended September 30, 2017 PR Newswire XIANYANG, China, Nov. 20, 2017 XIANYANG, China, Nov. 20, 2017 /PRNewswire/...
Biostar Pharmaceuticals, Inc. Announces Its Quarterly Results for Three Months Ended June 30, 2017 PR Newswire XIANYANG, China, Nov. 15, 2017 XIANYANG, China, Nov. 15, 2017 /PRNewswire/ - Biostar...
Biostar Announces Receipt of Nasdaq Continued Listing Deficiency Notice PR Newswire XIANYANG, China, Aug. 28, 2017 XIANYANG, China, Aug. 28, 2017 /PRNewswire/ -- Biostar Pharmaceuticals, Inc...
Biostar Pharmaceuticals, Inc. Announces Its Quarterly Results for Three Months Ended March 31, 2017 PR Newswire XIANYANG, China, May 19, 2017 XIANYANG, China, May 19, 2017 /PRNewswire/ - Biostar...
Biostar Pharmaceuticals, Inc. Announces Its Annual Results for The Year Ended December 31, 2016 PR Newswire XIANYANG, China, April 13, 2017 XIANYANG, China, April 13, 2017 /PRNewswire/ - Biostar...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 4 | 0 | 0 | 1.0E-6 | 1.0E-6 | 1.0E-6 | 143 | 1.0E-6 | CS |
| 12 | 0 | 0 | 1.0E-6 | 0.001 | 1.0E-6 | 1181 | 0.00012368 | CS |
| 26 | -9.9E-5 | -99 | 0.0001 | 0.001 | 1.0E-6 | 918 | 0.00012368 | CS |
| 52 | -9.9E-5 | -99 | 0.0001 | 0.001 | 1.0E-6 | 5929 | 3.451E-5 | CS |
| 156 | -9.9E-5 | -99 | 0.0001 | 0.01 | 1.0E-6 | 3755 | 0.0001116 | CS |
| 260 | -0.105099 | -99.9990485252 | 0.1051 | 0.379 | 1.0E-6 | 4495 | 0.09869786 | CS |
| Keine Diskussionen Gefunden. |
| Neuen Thread Erstellen |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
